Migraine Disorders

<section class="Section" data-sectioncode="34089-3"><a name="section-9"></a><h1>11        DESCRIPTION</h1>The active ingredient of QULIPTA is atogepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. The chemical name of atogepant is (3'S)-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide, and it has the following structural formula:<img alt="The active ingredient of TRADENAME is atogepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. The chemical name of atogepant is (S)-N-((3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide and has the following structural formula:" src="qulipta-01.jpg"/>The molecular formula is C29H23F6N5O3 and molecular weight is 603.5. Atogepant is a white to off-white powder. It is freely soluble in ethanol, soluble in methanol, sparingly soluble in acetone, slightly soluble in acetonitrile, and practically insoluble in water.QULIPTA is available as tablets for oral administration containing 10 mg, 30 mg, or 60 mg atogepant. The inactive ingredients include colloidal silicon dioxide, croscarmellose sodium, mannitol, microcrystalline cellulose, polyvinylpyrrolidone vinyl acetate copolymer, sodium chloride, sodium stearyl fumarate, and vitamin E polyethylene glycol succinate.</section>

Qulipta

atogepant

atogepant 10 MG Oral Tablet

atogepant 10 MG Oral Tablet [Qulipta]

atogepant 30 MG Oral Tablet

atogepant 30 MG Oral Tablet [Qulipta]

atogepant 60 MG Oral Tablet

atogepant 60 MG Oral Tablet [Qulipta]

Summit Cancer Centers

Qulipta | Summit Cancer Centers

Does Summit Cancer Centers work closely with Qulipta and AbbVie Inc.?

Does Summit Cancer Centers offer services for Qulipta patients?

What conditions does Summit Cancer Centers support?